Filing Details

Accession Number:
0001567619-21-012540
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-23 17:12:13
Reporting Period:
2021-06-23
Accepted Time:
2021-06-23 17:12:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533743 Processa Pharmaceuticals Inc. PCSA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378166 David Young C/O Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive, Suite 106
Hanover MD 21076
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-23 10,000 $7.67 345,190 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 548,783 Indirect By Young-Plaisance Revocable Trust
Common Stock 689,004 Indirect By Family Entities
Common Stock 55,258 Indirect By CorLyst, LLC